Trump accelerates research on psychedelic treatments and asks, ‘Can I have some?’ - CNN
Quick Insights
The Bottom Line
President Donald Trump is accelerating research into psychedelic treatments and personally inquired about receiving them.
How This Affects You
This initiative could lead to new federally approved treatment options for mental health conditions like PTSD and depression.
AI Summary
President Donald Trump is accelerating research into psychedelic treatments and personally inquired about receiving them, according to CNN. This initiative marks a significant shift in federal policy regarding substances like psilocybin and MDMA, which have historically been subject to strict federal prohibitions. The move suggests a potential expansion of federally funded studies into psychedelics for therapeutic uses, particularly for conditions like PTSD and depression. Such an acceleration could lead to new treatment options for veterans and others suffering from mental health challenges. President Trump's personal interest highlights a growing bipartisan curiosity in the medical potential of these compounds.
Source Coverage Map
13 of 43 tracked sources covered this story
Following this story?
Get notified when new coverage appears
Other Sources Covering This Story
5 sourcesMultiple outlets have reported on this story. Compare perspectives from different sources.
Trump speeds review of psychedelics after Joe Rogan texted him about ibogaine. 'Let's do it' - Fortune
Trump announces reforms to accelerate access to psychedelic drug treatments - The Guardian
Podcasters, Presidents, and Psychedelics: How Joe Rogan Got Trump Into Ibogaine
This article is part of a story we're tracking:
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump has signed an executive order to fast-track the review and research of psychedelic drugs for mental health disorders. This move aims to accelerate access to treatments like psilocybin and ibogaine, with the President publicly endorsing their potential.
Trump Administration Accelerates Psychedelic Drug Research
President Donald Trump signed an executive order to accelerate research and review of psychedelic drugs like psilocybin and ibogaine for mental health treatments. This move aims to fast-track their potential medical applications, with figures like Joe Rogan joining the announcement.
Trump's Executive Order on Psychedelic Research
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics, including ibogaine, LSD, and psilocybin, for mental health treatments. This move aims to expand access to these substances and expedite their review process.
Trump Administration's Psychedelic Drug Research Initiative
President Trump has signed an executive order to accelerate research and review of psychedelic drugs for mental health disorders, including psilocybin and ibogaine. This initiative aims to expand access to these therapies, with podcaster Joe Rogan reportedly influencing the decision.
Trump Administration's Psychedelic Drug Initiative
President Trump signed an executive order to accelerate access to psychedelic drug treatments and research for mental health. This initiative aims to expand the availability of substances like LSD, psilocybin, and ibogaine for medical use.
Trump Executive Order on Psychedelic Drug Research
President Trump signed an executive order to accelerate research and access to psychedelic drug treatments for mental health disorders. The initiative aims to fast-track the review process for substances like psilocybin and ibogaine.
US Political Figures and Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and ease restrictions on psychedelic drug treatments for mental health disorders. This move has drawn attention from various political figures and media outlets, including podcaster Joe Rogan.
Trump Administration's Push for Psychedelic Drug Research
President Trump has signed an executive order to accelerate research and review processes for psychedelic-based therapies. This initiative, reportedly influenced by Joe Rogan, aims to loosen restrictions and explore the potential of psychedelics for mental health disorders.
Trump Administration's Psychedelic Drug Review
President Donald Trump has signed an executive order to accelerate the review and research of psychedelic-based therapies for mental health disorders. This move, reportedly influenced by figures like Joe Rogan, aims to fast-track access to treatments like ibogaine and psilocybin.
Trump's Psychedelics Research Initiative
President Trump signed an executive order to ease restrictions and accelerate research into psychedelics like ibogaine, LSD, and psilocybin for potential medical applications, particularly in mental health treatment. The initiative aims to expand access to these substances and expedite their review process.
Should this be getting more attention?
You Might Have Missed
Related stories from different sources and perspectives
HealthFDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics
President Trump has signed an executive order to expand research into psychedelic drugs for mental health treatment. Dr. Marty Makary, commissioner of the Food and Drug Administration, joins CBS News to discuss.
PoliticsUS Justice Department adds former Trump lawyer to probe of former CIA director, CNN reports - Reuters
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOS0lJQmdXVG1hU2cxdVB6eElqYUpVcXR5WURXdE13V1hON1ZOSkxaTmJVc1ZER0QtNkhCM1lrelJMZWEyd3VaVUxuV3hVZUFvYlBRRVdnUGpJWFNFYmJLVmNmak5Oem1iQVVVTnNnYUYwbDlQcTNFUHU1cmtaTlBfbEo4VlpyLXhqOTNTbXI2N04yanFPdGhwd3hraHVtMTFuSkNFVUVhcmhsVjhwMFZWTjR4LWVCRFpnTm50bkcxSlZteVhNOTVObXVkTms?oc=5" target="_blank">US Justice Department adds former Trump lawyer to probe of former CIA director, CNN reports</a> <font color="#6f6f6f">Reuters</font>
PoliticsWhat to Know About Trump’s New Executive Order on Psychedelic Drugs
The order calls for the FDA to give expedited consideration to certain psychedelic drugs.
Government TransparencyNational Science Foundation’s future in limbo as Trump eyes cuts
The National Science Foundation’s (NSF) future is in limbo as President Trump pushes for more budget cuts and his nominee to helm the research agency awaits Senate confirmation. Since Trump’s return to the White House, the administration has canceled or suspended nearly 1,400 of the agency’s grants, citing changing policy priorities. A series of internal…
PoliticsPresident Trump’s Landmark Order Advances Breakthrough Mental Health Treatments — Delivering New Hope to Veterans - The White House (.gov)
GlobalTrump’s ‘Board of Peace’ holds talks with DP World on rebuilding Gaza, FT says - Reuters
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOenBQckdVVHc2UUVfMlljb0NZMU5acnA2RmNCdk1fX2ctRGFrUWN2Z29qQTR0ZTk3ZGdTZkJReC1sQ0RLS0VVZnF6V0p0djFaeFU0MXltb1ZDTkczTUp1YUREZTZlYVNSNEJySXZmV1dFRnd1dU9LdWtGQXE4MmRaS29ISmxVWXFpU21mRmg5Zkgyc1Y0dl9LZEREUVJFcnJjZlBjRlhzck4tME1DN085QzktTWpnSEZ5S3hZcnNZYw?oc=5" target="_blank">Trump’s ‘Board of Peace’ holds talks with DP World on rebuilding Gaza, FT says</a> <font color="#6f6f6f">Reuters</font>
Louisiana gunman had sought mental health treatment, relatives say
The man who killed eight children and wounded two women in Louisiana had sought mental health care from Veterans Affairs.
Did this story change how you see things?
Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.
The Verity Ledger curates verified investigative journalism from trusted sources only.
See our sourcesMost Read This Week
Report: Merck’s blockbuster cancer drug topped $200,000 a year under Trump
Trump’s Memphis Crime Task Force Arrested Over 800 Immigrants, Records Show. Only 2% of the Arrests Were for Violent Crimes.
Bipartisan duo that pushed Swalwell, Gonzales to resign says other lawmakers may be next
White House ramps up pressure to pass crypto bill as Congress returns
One in three Americans forced to make financial sacrifices for health coverage
